mRNA |
OSI-930 |
GDSC1000 |
pan-cancer |
AAC |
0.092 |
0.009 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.01 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
-0.09 |
0.01 |
mRNA |
ZM-447439 |
GDSC1000 |
pan-cancer |
AAC |
0.094 |
0.01 |
mRNA |
CEP-701 |
GDSC1000 |
pan-cancer |
AAC |
0.084 |
0.01 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.01 |
mRNA |
ATRA |
GDSC1000 |
pan-cancer |
AAC |
0.086 |
0.01 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.01 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.01 |